Abstract
Abstract
Introduction
Omphalocele (OM) is a congenital defect of the abdominal wall. The main goal of the
surgical management is the survival of the neonate. However, the residual scar
following the surgery can be extremely burdensome and negatively impact the quality
of life (QoL) of these patients. The aim of this study is to assess the cosmetic results of
the surgical treatment, the level of satisfaction of patients and surgeons, and the
influence of the scar on the QoL of the patient.
Materials and methods
We conducted an observational retrospective cross-sectional study collecting all data
regarding patients born with OM, operated at our Centre between 1998 and 2021. The
cosmetic results of the surgical repair were evaluated using the validated Patient and Observer Scar Assessment Scale (POSAS). The assessment of the quality of life
determined by the presence of the scar was conducted using PedQL 4.0. At last, the
patients were visited by two paediatric surgeons and a medical student, which then
scored the cosmetic result of the scar. Statistical analysis was conducted with
Spearman linear correlation and Mann–Whitney test. A P-value below 0.05 was considered statistically significant.
Results
In our study, we included a total of 19 patients, with a mean of 12 years of age at the
time of the evaluation. The parameters with the major influence on the patient’s general
opinion of the scar were stiffness, thickness, and irregularity. We discovered significant
differences in median values of all scores between the giant OM group and the nongiant
OM group, in favour of the latter. Finally, we found a low grade of concordance
between PedsQL filled by parents and patients.
Conclusion
The POSAS scale is a valid, feasible, and reliable tool for the assessment of the aesthetic outcome of surgical procedures. The original size of the defect is the most important factor acting on the result. However, it is crucial that any decision on plastic surgery to improve the looks of the scar must be postponed to the adult age of the patient.
Level of Evidence IV
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Funder
Alma Mater Studiorum - Università di Bologna
Publisher
Springer Science and Business Media LLC